• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过随机建模深入了解澳大利亚的淋球菌监测计划

Enhancing Insights into Australia's Gonococcal Surveillance Programme through Stochastic Modelling.

作者信息

Do Phu Cong, Alemu Yibeltal Assefa, Reid Simon Andrew

机构信息

School of Public Health, Faculty of Medicine, University of Queensland, Herston, QLD 4006, Australia.

出版信息

Pathogens. 2023 Jul 4;12(7):907. doi: 10.3390/pathogens12070907.

DOI:10.3390/pathogens12070907
PMID:37513754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10385950/
Abstract

Continued surveillance of antimicrobial resistance is critical as a feedback mechanism for the generation of concerted public health action. A characteristic of importance in evaluating disease surveillance systems is representativeness. Scenario tree modelling offers an approach to quantify system representativeness. This paper utilises the modelling approach to assess the Australian Gonococcal Surveillance Programme's representativeness as a case study. The model was built by identifying the sequence of events necessary for surveillance output generation through expert consultation and literature review. A scenario tree model was developed encompassing 16 dichotomous branches representing individual system sub-components. Key classifications included biological sex, clinical symptom status, and location of healthcare service access. The expected sensitivities for gonococcal detection and antibiotic status ascertainment were 0.624 (95% CI; 0.524, 0.736) and 0.144 (95% CI; 0.106, 0.189), respectively. Detection capacity of the system was observed to be high overall. The stochastic modelling approach has highlighted the need to consider differential risk factors such as sex, health-seeking behaviours, and clinical behaviour in sample generation. Actionable points generated by this study include modification of clinician behaviour and supplementary systems to achieve a greater contextual understanding of the surveillance data generation process.

摘要

持续监测抗菌药物耐药性作为协调公共卫生行动的反馈机制至关重要。评估疾病监测系统时一个重要的特征是代表性。情景树建模提供了一种量化系统代表性的方法。本文以澳大利亚淋球菌监测项目为例,利用该建模方法评估其代表性。该模型通过专家咨询和文献回顾确定产生监测输出所需的事件序列来构建。开发了一个情景树模型,包含16个二分法分支,代表各个系统子组件。关键分类包括生物性别、临床症状状态和获得医疗服务的地点。淋球菌检测和抗生素状态确定的预期敏感度分别为0.624(95%置信区间;0.524,0.736)和0.144(95%置信区间;0.106,0.189)。总体观察到该系统的检测能力较高。随机建模方法突出了在样本生成中考虑性别、求医行为和临床行为等不同风险因素的必要性。本研究产生的可操作要点包括改变临床医生行为和补充系统,以更好地从背景角度理解监测数据生成过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/380d9cf8a7a4/pathogens-12-00907-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/799aa1a271e5/pathogens-12-00907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/511a1b9dd53f/pathogens-12-00907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/61b3706a4a71/pathogens-12-00907-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/af0c2dd50f47/pathogens-12-00907-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/43abe41c84b6/pathogens-12-00907-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/4135be201d00/pathogens-12-00907-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/85aa78f8de07/pathogens-12-00907-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/7b0413c221ad/pathogens-12-00907-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/380d9cf8a7a4/pathogens-12-00907-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/799aa1a271e5/pathogens-12-00907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/511a1b9dd53f/pathogens-12-00907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/61b3706a4a71/pathogens-12-00907-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/af0c2dd50f47/pathogens-12-00907-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/43abe41c84b6/pathogens-12-00907-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/4135be201d00/pathogens-12-00907-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/85aa78f8de07/pathogens-12-00907-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/7b0413c221ad/pathogens-12-00907-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b1/10385950/380d9cf8a7a4/pathogens-12-00907-g009.jpg

相似文献

1
Enhancing Insights into Australia's Gonococcal Surveillance Programme through Stochastic Modelling.通过随机建模深入了解澳大利亚的淋球菌监测计划
Pathogens. 2023 Jul 4;12(7):907. doi: 10.3390/pathogens12070907.
2
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目,美国 27 个监测点,2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
3
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.欧洲淋球菌抗菌药物监测计划(Euro-GASP)恰当地反映了欧盟/欧洲经济区淋病奈瑟菌的抗菌药物耐药情况。
BMC Infect Dis. 2019 Dec 10;19(1):1040. doi: 10.1186/s12879-019-4631-x.
4
The European gonococcal antimicrobial surveillance programme, 2009.欧洲淋球菌抗菌药物监测项目,2009 年。
Euro Surveill. 2011 Oct 20;16(42):19995.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.欧洲耐抗菌药物淋病奈瑟菌的危险因素。
Sex Transm Dis. 2014 Dec;41(12):723-9. doi: 10.1097/OLQ.0000000000000185.
7
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.俄罗斯淋球菌抗菌药物敏感性方案(RU-GASP)——2009 年至 2012 年期间淋病奈瑟菌的耐药性和 2011 年和 2012 年的 NG-MAST 基因型。
BMC Infect Dis. 2014 Jun 19;14:342. doi: 10.1186/1471-2334-14-342.
8
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1999. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.1999年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测。世界卫生组织西太平洋区域淋球菌抗菌药物监测计划。
Commun Dis Intell. 2000 Sep;24(9):269-71. doi: 10.33321/cdi.2000.24.46.
9
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic .煤矿中的金丝雀:共生菌中的耐药性监测如何有助于遏制病原菌中 AMR 的传播
mBio. 2022 Oct 26;13(5):e0199122. doi: 10.1128/mbio.01991-22. Epub 2022 Sep 26.
10
Biomedical Response to Neisseria gonorrhoeae and Other Sexually Transmitted Infections in the US Military.美国军队对淋病奈瑟菌及其他性传播感染的生物医学反应。
Mil Med. 2019 Nov 1;184(Suppl 2):51-58. doi: 10.1093/milmed/usy431.

引用本文的文献

1
Policy, practice, and prediction: model-based approaches to evaluating N. gonorrhoeae antibiotic susceptibility test uptake in Australia.政策、实践与预测:基于模型的方法评估澳大利亚淋病奈瑟菌抗生素药敏试验采用率
BMC Infect Dis. 2024 May 17;24(1):498. doi: 10.1186/s12879-024-09393-y.

本文引用的文献

1
Australian Gonococcal Surveillance Programme Annual Report, 2021.澳大利亚淋球菌监测计划年度报告,2021 年。
Commun Dis Intell (2018). 2022 Aug 18;46. doi: 10.33321/cdi.2022.46.52.
2
Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia.赞比亚卢萨卡市城区医院性传播感染门诊分离的淋病奈瑟菌的抗菌药物耐药性。
BMC Infect Dis. 2022 Aug 12;22(1):688. doi: 10.1186/s12879-022-07674-y.
3
Gender and Antimicrobial Resistance: What Can We Learn From Applying a Gendered Lens to Data Analysis Using a Participatory Arts Case Study?
性别与抗微生物药物耐药性:通过参与式艺术案例研究将性别视角应用于数据分析,我们能学到什么?
Front Glob Womens Health. 2022 May 27;3:745862. doi: 10.3389/fgwh.2022.745862. eCollection 2022.
4
Centers for Disease Control and Prevention's Sexually Transmitted Diseases Infection Guidelines.疾病控制与预防中心性传播疾病感染指南。
Clin Infect Dis. 2022 Apr 13;74(74 Suppl 2):S89-S94. doi: 10.1093/cid/ciab1055.
5
Assessment of the Current Surveillance System for Human Leptospirosis in Ecuador by Decision Analytic Modeling.厄瓜多尔人类钩端螺旋体病现行监测系统评估:决策分析模型。
Front Public Health. 2022 Mar 3;10:711938. doi: 10.3389/fpubh.2022.711938. eCollection 2022.
6
Use of scenario tree modelling to plan freedom from infection surveillance: Mycoplasma bovis in New Zealand.应用情景树模型规划感染监测免疫情景:新西兰牛支原体。
Prev Vet Med. 2022 Jan;198:105523. doi: 10.1016/j.prevetmed.2021.105523. Epub 2021 Oct 26.
7
Gonorrhoea: a systematic review of prevalence reporting globally.淋病:全球流行率报告的系统评价。
BMC Infect Dis. 2021 Nov 11;21(1):1152. doi: 10.1186/s12879-021-06381-4.
8
Australian Gonococcal Surveillance Programme Annual Report, 2020.澳大利亚淋球菌监测计划年度报告,2020 年。
Commun Dis Intell (2018). 2021 Oct 28;45. doi: 10.33321/cdi.2021.45.58.
9
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.微生物耐药动态:对抗菌药物耐药性所构成的全球公共卫生威胁的概述以及最佳应对方法。
Front Public Health. 2020 Nov 4;8:535668. doi: 10.3389/fpubh.2020.535668. eCollection 2020.
10
Antibiotic resistance surveillance systems: A review.抗生素耐药性监测系统:综述。
J Glob Antimicrob Resist. 2020 Dec;23:430-438. doi: 10.1016/j.jgar.2020.10.009. Epub 2020 Nov 8.